Stem Cells, Superstars, And Supershow: WWE Superstar Elias Set to Face Off at WrestleCade SuperShow 2024 This Weekend
ADIA Nutrition (OTC Pink: ADIA) announced its partner Jeff Sciullo (WWE's Elias) will compete at WrestleCade SuperShow 2024. More importantly, the company's medical division, ADIA Med, is preparing to open an Autologous Hematopoietic Stem Cell Transplantation (AHSCT) clinic for Multiple Sclerosis by Christmas in Winter Park, Florida. The facility will offer experimental treatments using umbilical cord stem cells. Additionally, ADIA has established ADIA Labs to distribute umbilical cord stem cells to doctors and clinics nationwide, focusing on Mesenchymal Stem Cells (MSCs) for homologous use in regenerative medicine.
ADIA Nutrition (OTC Pink: ADIA) ha annunciato che il suo partner Jeff Sciullo (Elias della WWE) parteciperà al WrestleCade SuperShow 2024. Ancora più importante, la divisione medica dell'azienda, ADIA Med, si sta preparando ad aprire una clinica per il Trapianto di Cellule Staminali Ematopoietiche Autologhe (AHSCT) per la Sclerosi Multipla entro Natale a Winter Park, Florida. La struttura offrirà trattamenti sperimentali utilizzando cellule staminali del cordone ombelicale. Inoltre, ADIA ha creato ADIA Labs per distribuire cellule staminali del cordone ombelicale a medici e cliniche in tutto il paese, concentrandosi sulle Cellule Staminali Mesenchimali (MSCs) per l'uso omologo nella medicina rigenerativa.
ADIA Nutrition (OTC Pink: ADIA) anunció que su socio Jeff Sciullo (Elias de la WWE) competirá en el WrestleCade SuperShow 2024. Más importante aún, la división médica de la empresa, ADIA Med, se está preparando para abrir una clínica de Trasplante de Células Madre Hematopoyéticas Autólogas (AHSCT) para la Esclerosis Múltiple antes de Navidad en Winter Park, Florida. La instalación ofrecerá tratamientos experimentales utilizando células madre del cordón umbilical. Además, ADIA ha establecido ADIA Labs para distribuir células madre del cordón umbilical a médicos y clínicas en todo el país, centrando su atención en las Células Madre Mesenquimatosas (MSCs) para su uso homólogo en medicina regenerativa.
ADIA Nutrition (OTC Pink: ADIA)는 파트너인 제프 시울로(WWE의 엘리아스)가 2024년 WrestleCade SuperShow에 출전할 것이라고 발표했습니다. 더 중요한 것은, 회사의 의료 부문인 ADIA Med가 플로리다주 윈터파크에 있는 자기 조혈모세포 이식(AHSCT) 클리닉을 크리스마스 전에 열 준비를 하고 있다는 점입니다. 이 시설은 제대혈 줄기세포를 사용한 실험적 치료법을 제공할 예정입니다. 또한, ADIA는 ADIA Labs를 설립하여 전국의 의사와 클리닉에 제대혈 줄기세포를 배포하며, 재생 의학에서 동종 사용을 위한 간엽 줄기세포(MSCs)에 집중하고 있습니다.
ADIA Nutrition (OTC Pink: ADIA) a annoncé que son partenaire Jeff Sciullo (Elias de la WWE) participera au WrestleCade SuperShow 2024. Plus important encore, la division médicale de l'entreprise, ADIA Med, se prépare à ouvrir une clinique de transplantation de cellules souches hématopoïétiques autologues (AHSCT) pour la sclérose en plaques d'ici Noël à Winter Park, en Floride. L'établissement proposera des traitements expérimentaux utilisant des cellules souches de cordon ombilical. De plus, ADIA a établi ADIA Labs pour distribuer des cellules souches de cordon ombilical à des médecins et des cliniques dans tout le pays, en se concentrant sur les cellules souches mésenchymateuses (MSC) pour un usage homologue en médecine régénérative.
ADIA Nutrition (OTC Pink: ADIA) gab bekannt, dass sein Partner Jeff Sciullo (Elias von der WWE) beim WrestleCade SuperShow 2024 antreten wird. Noch wichtiger ist, dass die medizinische Abteilung des Unternehmens, ADIA Med, sich darauf vorbereitet, eine Klinik für Autologe Hämatopoetische Stammzelltransplantation (AHSCT) für Multiple Sklerose bis Weihnachten in Winter Park, Florida, zu eröffnen. Die Einrichtung wird experimentelle Behandlungen mit Nabelschnur-Stammzellen anbieten. Darüber hinaus hat ADIA ADIA Labs gegründet, um Nabelschnur-Stammzellen an Ärzte und Kliniken im ganzen Land zu verteilen, mit einem Fokus auf mesenchymale Stammzellen (MSCs) für homologe Anwendungen in der regenerativen Medizin.
- Opening of AHSCT clinic for Multiple Sclerosis treatment by Christmas
- Establishment of ADIA Labs for nationwide stem cell distribution
- Expansion into experimental umbilical cord stem cell treatments
- None.
WINTER PARK, Fla., Nov. 26, 2024 (GLOBE NEWSWIRE) -- ADIA Nutrition (OTC Pink: ADIA) is proud to announce that this weekend, Jeff Sciullo, known in the wrestling world as Elias from WWE and business partner to ADIA Nutrition in their Cement Factory venture, will compete against Psycho Boy Fodder at the 2024 WrestleCade SuperShow. Psycho Boy Fodder and his team manage the marketing as well as the website design for Cement Factory. This match, organized by a third party, showcases the diverse interests of ADIA Nutrition's partners but is not affiliated with the company's medical or business ventures.
"While our focus is on healthcare innovation, this wrestling event is a fun, personal celebration for Jeff and his team," stated Larry Powalisz, CEO of ADIA Nutrition. "We wish them all the best in their match!"
ADIA Nutrition’s medical division, ADIA Med, is on track to open its pioneering Autologous Hematopoietic Stem Cell Transplantation (AHSCT) clinic for Multiple Sclerosis (MS) by Christmas. Located in Winter Park, Florida, this facility will also introduce experimental treatments using umbilical cord stem cells, marking a significant advancement in regenerative medicine.
The Regenerative HOPE of Stem Cells
Stem cells are at the forefront of regenerative medicine due to studies that show their extraordinary capacity to repair, regenerate, or even replace damaged tissues. Their ability to differentiate into various cell types offers potential treatments for a broad spectrum of conditions, from heart disease and stroke to diabetes and neurodegenerative diseases.
Umbilical cord
Focus on Mesenchymal Stem Cells (MSCs) for Homologous Use
ADIA Med will particularly explore the use of Mesenchymal Stem Cells (MSCs), especially from Umbilical Cord sources, for homologous use. These cells are multipotent stromal cells found in tissues like bone marrow, adipose tissue, and the umbilical cord. MSCs are known for:
- Immunomodulatory Properties: MSCs may be able to regulate the immune system, which is crucial for managing autoimmune diseases by potentially reducing inflammation.
- Tissue Repair: They have the potential ability to differentiate into various cell types, aiding in tissue regeneration, which could be beneficial for neurological repair.
- Paracrine Effects: MSCs secrete growth factors and cytokines that could stimulate local tissue repair and regeneration, supporting recovery without necessarily transforming into the tissue type.
Homologous use under FDA regulations allows MSCs to be used in ways consistent with their natural biological functions, which might simplify the regulatory pathway for these treatments compared to non-homologous uses.
Introducing ADIA Labs LLC
To support the clinic's operations and expansion into informed consent treatments, ADIA Nutrition has established "ADIA Labs LLC." This new entity will distribute umbilical cord stem cells to doctors and clinics nationwide, ensuring a high-quality supply for clinical use. "ADIA Labs LLC is our commitment to bringing innovative stem cell therapies to those who need them," said Larry Powalisz, CEO of ADIA Nutrition. Further details will be shared as developments unfold.
For media inquiries or further information, please contact Larry Powalisz at ceo@adiamed.com or 321-788-0850.
About ADIA Nutrition Inc.:
ADIA Nutrition Inc. is a publicly traded company (OTC Pink: ADIA) dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division establishing Clinics that specialize in Autologous Hematopoietic Stem Cell Transplantation (AHSCT) treatments for Multiple Sclerosis (MS). Through these divisions, ADIA Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments.
Website: www.adianutrition.com
Website: www.adia-med.com
Website: www.biolete.com
Website: www.cementfactory.co
Twitter (X): @ADIA_Nutrition
Safe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a few uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, because of new information, future events or otherwise.
Photos accompanying this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/a4533ae7-d79b-4f2f-9b88-53698d9f8a42
https://www.globenewswire.com/NewsRoom/AttachmentNg/c9c9bbf0-f7aa-4287-8b53-8d6ed76e3a2b
FAQ
When will ADIA Nutrition's stem cell clinic open in Winter Park, Florida?
What type of stem cells will ADIA (ADIA) use in their treatments?
What is the purpose of ADIA Labs ?
